Proteomic profiling reveals a distinctive molecular signature for critically ill COVID-19 patients compared with asthma and chronic obstructive pulmonary disease

OBJECTIVE: The mortality rate for critically ill COVID-19 cases was more than 80%. Nonetheless, research about the effect of common respiratory diseases on critically ill COVID-19 expression and outcomes is scarce. DESIGN: We performed proteomic analyses on airway mucus obtained by bronchoscopy from...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zili, Lin, Fanjie, Liu, Fei, Li, Qiongqiong, Li, Yuanyuan, Zhu, Zhanbei, Guo, Hua, Liu, Lidong, Liu, Xiaoqing, Liu, Wei, Fang, Yaowei, Wei, Xinguang, Lu, Wenju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743279/
https://www.ncbi.nlm.nih.gov/pubmed/35017110
http://dx.doi.org/10.1016/j.ijid.2022.01.008

Ejemplares similares

Ejemplares similares